Cargando…
Gliosarcoma vs. glioblastoma: a retrospective case series using molecular profiling
BACKGROUND: Gliosarcoma (GS) refers to the presence of mesenchymal differentiation (as seen using light microscopy) in the setting of glioblastoma (GB, an astrocytoma, WHO Grade 4). Although the same approach to treatment is typically adopted for GS and GB, there remains some debate as to whether GS...
Autores principales: | Dardis, Christopher, Donner, David, Sanai, Nader, Xiu, Joanne, Mittal, Sandeep, Michelhaugh, Sharon K., Pandey, Manjari, Kesari, Santosh, Heimberger, Amy B., Gatalica, Zoran, Korn, Michael W., Sumrall, Ashley L., Phuphanich, Surasak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220715/ https://www.ncbi.nlm.nih.gov/pubmed/34162346 http://dx.doi.org/10.1186/s12883-021-02233-5 |
Ejemplares similares
-
Correction to: Gliosarcoma vs. glioblastoma: a retrospective case series using molecular profiling
por: Dardis, Christopher, et al.
Publicado: (2021) -
Primary CNS lymphoma commonly expresses immune response biomarkers
por: Ou, Alexander, et al.
Publicado: (2020) -
Molecular alterations associated with improved outcome in patients with glioblastoma treated with Tumor-Treating Fields
por: Pandey, Manjari, et al.
Publicado: (2022) -
Multi-platform molecular profiling of a large cohort of glioblastomas reveals potential therapeutic strategies
por: Xiu, Joanne, et al.
Publicado: (2016) -
Rethinking medulloblastoma from a targeted therapeutics perspective
por: Hashimoto, Yuuri, et al.
Publicado: (2018)